Gibraltar Capital Management, Inc. Gilead Sciences, Inc. Transaction History

Gibraltar Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$62.32 - $89.47 $13,897 - $19,951	-223 Reduced 2.49%	8,725 $0
Q3 2022 Oct 26, 2022	BUY	$59.54 - $68.01 $160,222 - $183,014	2,691 Added 43.01%	8,948 $552,000
Q2 2022 Jul 19, 2022	BUY	$57.72 - $65.01 $7,099 - $7,996	123 Added 2.01%	6,257 $387,000
Q1 2022 Apr 11, 2022	BUY	$57.92 - $72.58 $111,611 - $139,861	1,927 Added 45.8%	6,134 $365,000
Q4 2021 Jan 21, 2022	BUY	$64.88 - $73.64 $272,950 - $309,803	4,207 New	4,207 $305,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Gibraltar Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Gibraltar Capital Management, Inc. with notifications on news.